Diabetes, hypertension and hyperlipidemia: Prevalence over time and impact on long-term survival after liver transplantation

American Journal of Transplantation

Volumn 12, Issue 8, 2012, Pages 2181-2187

  Parekh, J ^a   Corley, D A ^b   Feng, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Liver transplantation; metabolic disorders; mortality

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN;

ADULT; ALLOGRAFT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE DURATION; END STAGE LIVER DISEASE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN TREATMENT; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL INFECTION;

ADULT; CALIFORNIA; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84864433273     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04077.x     Document Type: Article

References (13)

1. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. Department of Health and Human Services.
2. Hanouneh IA, Feldstein AE, McCullough AJ, et al,. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008; 14: 1287-1293.
3. Laryea M, Watt KD, Molinari M, et al,. Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109-1114.
4. Stegall MD, Everson G, Schroter G, et al,. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 1995; 60: 1057-1060.
5. Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ,. Posttransplant metabolic syndrome: An epidemic waiting to happen. Liver Transpl 2009; 15: 1662-1670.
6. John PR, Thuluvath PJ,. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002; 8: 708-713.
7. Watt KD, Pedersen RA, Kremers WK, et al,. Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-1427.
8. Baid S, Cosimi AB, Farrell ML, et al,. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066-1072.
9. Seo S, Maganti K, Khehra M, et al,. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 2007; 13: 844-847.
10. Demirci MS, Toz H, Yilmaz F, et al,. Risk factors and consequences of post-transplant diabetes mellitus. Clin Transplant 2010; 24: E170-E177.
11. Pawarode A, Fine DM, Thuluvath PJ,. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741-747.
12. Paramesh AS, Roayaie S, Doan Y, et al,. Post-liver transplant acute renal failure: Factors predicting development of end-stage renal disease. Clin Transplant 2004; 18: 94-99.
13. Moon JI, Barbeito R, Faradji RN, et al,. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation 2006; 82: 1625-1628.